| The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies? MR Wills, E Poole, B Lau, B Krishna, JH Sinclair Cellular & molecular immunology 12 (2), 128-138, 2015 | 155 | 2015 |
| The expression of human cytomegalovirus microRNA MiR-UL148D during latent infection in primary myeloid cells inhibits activin A-triggered secretion of IL-6 B Lau, E Poole, B Krishna, I Montanuy, MR Wills, E Murphy, J Sinclair Scientific reports 6 (1), 1-15, 2016 | 90 | 2016 |
| Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein BA Krishna, K Spiess, EL Poole, B Lau, S Voigt, TN Kledal, ... Nature communications 8 (1), 1-9, 2017 | 77 | 2017 |
| Suppression of costimulation by human cytomegalovirus promotes evasion of cellular immune defenses ECY Wang, M Pjechova, K Nightingale, VM Vlahava, M Patel, E Ruckova, ... Proceedings of the National Academy of Sciences 115 (19), 4998-5003, 2018 | 74 | 2018 |
| Transient activation of human cytomegalovirus lytic gene expression during latency allows cytotoxic T cell killing of latently infected cells BA Krishna, B Lau, SE Jackson, MR Wills, JH Sinclair, E Poole Scientific reports 6, 24674, 2016 | 66 | 2016 |
| Human cytomegalovirus miR-UL112-1 promotes the down-regulation of viral immediate early-gene expression during latency to prevent T-cell recognition of latently infected cells B Lau, E Poole, E Van Damme, L Bunkens, M Sowash, H King, E Murphy, ... The Journal of general virology 97 (9), 2387, 2016 | 60 | 2016 |
| Development and characterisation of monoclonal antibodies specific for the murine inhibitory FcγRIIB (CD32B) EL Williams, AL Tutt, RR French, HT Chan, B Lau, CA Penfold, ... European journal of immunology 42 (8), 2109-2120, 2012 | 60 | 2012 |
| Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+ R+ liver transplant patients E Van Damme, S Sauviller, B Lau, B Kesteleyn, P Griffiths, A Burroughs, ... The Journal of general virology 96 (Pt 1), 131, 2015 | 47 | 2015 |
| Human cytomegalovirus long noncoding RNA4. 9 regulates viral DNA replication J Tai-Schmiedel, S Karniely, B Lau, A Ezra, E Eliyahu, A Nachshon, ... PLoS Pathogens 16 (4), e1008390, 2020 | 45 | 2020 |
| Identification of compounds with anti-human cytomegalovirus activity that inhibit production of IE2 proteins R Beelontally, GS Wilkie, B Lau, CJ Goodmaker, CMK Ho, CM Swanson, ... Antiviral research 138, 61-67, 2017 | 15 | 2017 |
| Human cytomegalovirus long non-coding RNA1. 2 suppresses extracellular release of the pro-inflammatory cytokine IL-6 by blocking NF-κB activation B Lau, K Kerr, Q Gu, K Nightingale, R Antrobus, NM Suárez, RJ Stanton, ... Frontiers in cellular and infection microbiology 10, 361, 2020 | 14 | 2020 |
| Genomic analysis of chimeric human cytomegalovirus vaccine candidates derived from strains Towne and Toledo NM Suárez, B Lau, GM Kemble, R Lee, ES Mocarski, GWG Wilkinson, ... Virus genes 53 (4), 650-655, 2017 | 13 | 2017 |
| Corrigendum: the expression of human cytomegalovirus MicroRNA MiR-UL148D during latent infection in primary myeloid cells inhibits activin A-triggered secretion of IL-6 B Lau, E Poole, B Krishna, I Montanuy, MR Wills, E Murphy, J Sinclair Scientific reports 6, 2016 | 4 | 2016 |
| Insights into the roles of viral miRNAs, IE72 downregulation and myeloid differentiation during human cytomegalovirus latency and reactivation BCM Lau University of Cambridge, 2015 | | 2015 |
